Answer
Infusion-related reactions to ocrelizumab can occur during the infusion or within 24 hours of the infusion.
Sources for this answer
- OCREVUS 300 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 20Document updated
Sources checked